BioGlow Health vs Wholesome Clinic
Two sellers that publish every rung, at opposite ends of the coverage map.
BioGlow Health
Editorial
$129/mo
BioGlow Health prices compounded semaglutide from $129 at 1 mg to $249 at 10 mg, and compounded tirzepatide from $169 at 10 mg to $299 at 60 mg, with a three-month bundle at $399 on either molecule. The whole ladder is printed beside the entry figure rather than revealed at the third refill. The bill therefore rises as the dose does, by a published amount.
Pick it for: Readers who want the ladder and national shipping
Wholesome Clinic
Editorial
$109/mo
Wholesome Clinic publishes a dose ladder rather than a single figure for each product: compounded semaglutide runs $149 to $199 and above by injection, $109 to $199 as an oral, while compounded tirzepatide runs $349 to $549 by injection and $249 to $349 as an oral. All four are self-pay. The service covers seven states.
Pick it for: Readers inside its seven states comparing the lower opening rung
Our verdict
Both print the full ladder rather than an opening figure, which is rare. BioGlow ships to fifty states; Wholesome Clinic serves seven. The disclosure matches and the availability does not.
What actually separates them
BioGlow Health and Wholesome Clinic state different things about published price. Everything else they publish, they publish the same way.
BioGlow Health costs $20 more than Wholesome Clinic — 18% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,308 at Wholesome Clinic against $1,548 at BioGlow Health — a difference of $240.
| BioGlow Health | Wholesome Clinic | |
|---|---|---|
| Published price | $129/mo | $109/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.